Serrano-Combarro et al. Case series of upadacitinib in RA-ILD. 18 patients. Report stable/improved dyspnoea and HRCT ove
Tweet Content
Serrano-Combarro et al. Case series of upadacitinib in RA-ILD. 18 patients. Report stable/improved dyspnoea and HRCT over 12 months. PFTs shown, relatively stable @RheumNow #ACR24 Abstr#1372 https://t.co/yncy0lPq60 https://t.co/mrDMtEDwUt
Links
Upadacitinib and Other JAK Inhibitors in the Treatment of Rheumatoid Arthritis …
https://acrabstracts.org/abstract/upadacitinib-and-other-jak-inhibitors-in-the-…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off